Skip to main content
SpringerLink
Log in

Expression of protease-activated receptors on platelets in healthy individuals

  • Research Article
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

This study aimed to investigate the expression of protease-activated receptors (PARs) on platelets in healthy individuals and preliminarily elucidate physiological functions of PARs. Thirty healthy volunteers, who did not take any anticoagulants and antiplatelet agents within 10 days before the examination, were recruited. Fasting venous blood (5 mL) was taken from the medial cubital vein in each individual and platelet-rich plasma (PRP) was prepared. The expression of PAR1 mRNA and PAR4 mRNA in PRP was determined by RT-PCR analysis. The results showed that the average levels of PAR1 mRNA and PAR4 mRNA on platelets in healthy individuals were 0.1601 ± 0.0269 and 0.1073 ± 0.0194 respectively. In combination with literature analysis, it was concluded that the thrombin signaling pathway plays a vital role in the development of hemostasis and thrombosis, and the selective PARs antagonist has the potential for extensive application in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ruggeri Z M. Platelets in atherothrombosis. Nat Med, 2002, 8(11): 1227–1234

    Article  PubMed  CAS  Google Scholar 

  2. Kahn M L, Zheng Y W, Huang W, Bigornia V, Zeng D, Moff S, Farese R VJr, Tam C, Coughlin S R. A dual thrombin receptor system for platelet activation. Nature, 1998, 394(6694): 690–694

    Article  PubMed  CAS  Google Scholar 

  3. Coughlin S R. How the protease thrombin talks to cells. Proc Natl Acad Sci USA, 1999, 96(20): 11023–11027

    Article  PubMed  CAS  Google Scholar 

  4. Macfarlane S R, Seatter M J, Kanke T, Hunter G D, Plevin R. Proteinase-activated receptors. Pharmacol Rev, 2001, 53(2): 245–282

    Google Scholar 

  5. Faruqi T R, Weiss E J, Shapiro M J, Huang W, Coughlin S R. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. J Biol Chem, 2000, 275(26): 19728–19734

    Article  PubMed  CAS  Google Scholar 

  6. Hamilton J R, Frauman A G, Cocks T M. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res, 2001, 89(1): 92–98

    Article  PubMed  CAS  Google Scholar 

  7. Coughlin S R. Thrombin signalling and protease-activated receptors. Nature, 2000, 407(6801): 258–264

    Article  PubMed  CAS  Google Scholar 

  8. Kahn M L, Nakanishi-Matsui M, Shapiro M J, Ishihara H, Coughlin S R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest, 1999, 103(6): 879–887

    Article  PubMed  CAS  Google Scholar 

  9. Vu T K, Hung D T, Wheaton V I, Coughlin S R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 1991, 64(6): 1057–1068

    Article  PubMed  CAS  Google Scholar 

  10. Chen J, Ishii M, Wang L, Ishii K, Coughlin S R. Thrombin receptor activation: confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative liganding mode. J Biol Chem, 1994, 269(23): 16041–16045

    PubMed  CAS  Google Scholar 

  11. Reed G L. Platelet secretory mechanisms. Semin Thromb Hemost, 2004, 30(4): 441–450

    Article  PubMed  CAS  Google Scholar 

  12. Dorsam R T, Kunapuli S P. Central role of the P2Y12 receptor in platelet activation. J Clin Invest, 2004, 113(3): 340–345

    PubMed  CAS  Google Scholar 

  13. Cook J J, Sitko G R, Bednar B, Condra C, Mellott M J, Feng D M, Nutt R F, Shafer J A, Gould R J, Connolly TM. An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey. Circulation, 1995, 91(12): 2961–2971

    PubMed  CAS  Google Scholar 

  14. Sambrano G R, Weiss E J, Zheng Y W, Huang W, Coughlin S R. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature, 2001, 413(6851): 74–78

    Article  PubMed  CAS  Google Scholar 

  15. Pakala R, Liang C T, Benedict C R. Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor. Thromb Res, 2000, 100(1): 89–96

    Article  PubMed  CAS  Google Scholar 

  16. Hasan A A, Rebello S S, Smith E, Srikanth S, Werns S, Driscoll E, Faul J, Brenner D, Normolle D, Lucchesi B R, Schmaier A H. Thrombostatin inhibits induced canine coronary thrombosis. Thromb Haemost, 1999, 82(3): 1182–1187

    PubMed  CAS  Google Scholar 

  17. Connolly TM, Condra C, Feng DM, Cook J J, Stranieri MT, Reilly C F, Nutt R F, Gould R J. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb Haemost, 1994, 72(4): 627–633

    PubMed  CAS  Google Scholar 

  18. Derian C K, Santulli R J, Tomko K A, Haertlein B J, Andrade-Gordon P. Species differences in platelet responses to thrombin and SFLLRN. Receptor-mediated calcium mobilization and aggregation and regulation by protein kinases. Thromb Res, 1995, 78(6): 505–519

    Article  PubMed  CAS  Google Scholar 

  19. Zhang H C, Derian C K, Andrade-Gordon P, Hoekstra W J, McComsey D F, White K B, Poulter B L, Addo M F, Cheung WM, Damiano B P, Oksenberg D, Reynolds E E, Pandey A, Scarborough R M, Maryanoff B E. Discovery and optimization of a novel series of thrombin receptor (par-1) antagonists: potent, selective peptide mimetics based on indole and indazole templates. J Med Chem, 2001, 44(7): 1021–1024

    Article  PubMed  CAS  Google Scholar 

  20. Andrade-Gordon P, Derian C K, Maryanoff B E, Zhang H C, Addo M F, Cheung W M, Damiano B P, D’Andrea M R, Darrow A L, de Garavilla L, Eckardt A J, Giardino E C, Haertlein B J, McComsey D F. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J Pharmacol Exp Ther, 2001, 298(1): 34–42

    PubMed  CAS  Google Scholar 

  21. Derian C K, Damiano B P, Addo M F, Darrow A L, D’Andrea M R, Nedelman M, Zhang H C, Maryanoff B E, Andrade-Gordon P. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates. J Pharmacol Exp Ther, 2003, 304(2): 855–861

    Article  PubMed  CAS  Google Scholar 

  22. Ahn H S, Foster C, Boykow G, Stamford A, Manna M, Graziano M. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol, 2000, 60(10): 1425–1434

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Integrated Chinese andWestern Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Rui Zhu & Lin Shen

Authors
  1. Rui Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lin Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lin Shen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, R., Shen, L. Expression of protease-activated receptors on platelets in healthy individuals. Front. Med. China 3, 236–239 (2009). https://doi.org/10.1007/s11684-009-0040-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-009-0040-7

Keywords

Search

Navigation